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Endoluminal intervention for limb salvage after
failed lower extremity bypass graft
Hector F. Simosa, MD, Junaid Y. Malek, MD, Marc L. Schermerhorn, MD, Kristina A. Giles, MD,
Frank B. Pomposelli, MD, and Allen D. Hamdan, MD, Boston, Mass
Background: Lower extremity bypass graft failure in patients with limb-threatening ischemia carries an amputation rate
of greater than 50%. Redo bypass is often difficult due to the lack of conduit, adequate target, or increased surgical risk,
and resultant limb salvage rates are reduced significantly compared with the index operation. We set forth to investigate
whether endovascular treatment in this setting would result in an acceptable limb salvage rate.
Methods: A single-institution, retrospective review from June 2004 to December 2007 of patients with failed grafts who
underwent endovascular treatment with percutaneous balloon angioplasty (PTA) of their native circulation was
performed. Stents were selectively used in cases of post-PTA residual stenosis or flow-limiting dissection. Technical
success was defined as a residual stenosis less than 30%. Percutaneous attempts at bypass graft salvage were excluded.
Demographics, comorbidities, procedural data, and follow-up information were recorded. Descriptive, logistic regression
and life-table analyses were performed.
Results: Twenty-four lower extremities were treated in 23 patients with failed bypass grafts. Average patency of the index
graft before failure was 647 days (range 5-2758). Mean age was 68 years (range 51-85), 62% were male and 81% had
diabetes mellitus (DM). 87.5% of limbs treated had TransAtlantic InterSociety Consensus (TASC) C and D lesions and
62% had multiple lesions. Technical success was achieved in 100%. Mean follow-up was 25.6 months. At follow-up, there
were 17 PTA failures, which resulted in: amputation (4), redo-bypass (3), and redo-PTA (11). Freedom from surgical
revision and PTA failure was 89% (/ 0.07 SE) and 28% (/ 0.09 SE) respectively. PTA secondary patency was 72%
(/ 0.09 SE) and limb-salvage was 81% (/ 0.08 SE) at both 12 and 24 months. Overall survival was 83% (/
0.07 SE) and 77% (/ 0.09 SE) at 12 and 24 months, respectively.
Conclusions: Endovascular treatment of patients with previously failed bypass grafts results in a high rate of limb salvage. This
is a reasonable option in selected patients and the primary choice in those with poor targets, conduit, or excess surgical risk.
Endovascular salvage should be considered before proceeding to primary amputation. (J Vasc Surg 2009;49:1426-30.)The use of tibial or pedal bypass for the treatment of
critical limb ischemia has enjoyed a combination of excel-
lent durability with low mortality and exceptional amputa-
tion free survival.1 However, not all patients are candidates
for open revascularization due to lack of conduit, limited
life expectancy, unacceptable surgical risk, or nonambula-
tory status. More recently, percutaneous transluminal bal-
loon angioplasty (PTA) in the crural location has largely
replaced bypass surgery in certain groups.2
The Bypass Versus Angioplasty in Severe Ischemia of
the Leg (BASIL) trial recommended that primary PTA
might be an appropriate first therapy even if the patient is a
good candidate for bypass.3 PTA for limb threatening
ischemia in the infrapopliteal location, has demonstrated
primary and secondary patency rates of 53% and 83% at 12
months, and 51% and 63% at 36 months with limb salvage
rates above 85% at 3 years.4,5 However, major amputation
is still performed in patients with failed attempts at open
revascularization, severe comorbidity, extensive tissue loss,
or infection and anatomic factors precluding surgery. Ap-
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1426proximately, 60% of amputations are performed on patients
with previously failed lower extremity bypass grafts.6 We
here set forth to investigate the outcomes of PTA in this
group of patients.
METHODS
We performed a retrospective review of prospectively
collected data from July 2004 to October 2007 at the Beth
Israel Deaconess Medical Center and identified 24 lower
extremities in 23 patients who presented with critical limb
ischemia and a failed (occluded) bypass, all of whom un-
derwent ipsilateral infrainguinal PTA of their native circu-
lation. All these patients were immediately scheduled to
undergo diagnostic arteriography and were selected to
undergo PTA of their native circulation based on surgeon
preference, due to symptom severity, conduit availability,
presence of serious comorbid condition (worsening renal
or cardiac failure, or severe pulmonary disease), and grafts
were deemed unsalvageable. Cases in which both treatment
of native circulation as well as salvage attempts at the index
bypass graft were performed were excluded. Procedures
were performed initially in the operating room with a
mobile C-Arm (OEC-9800; General Electric Healthcare,
Dallas, Tex) unit with DSA capability, but most were done
in endovascular suites with fixed Philips (Allura Xper FD20;
Eindhoven, The Netherlands) and General Electric (LCV;
GE Healthcare, Dallas, Tex) imaging equipment.
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used in all or majority of cases. A 5 or 6F sheath is advanced
just proximal to the target lesion. The patient is fully
heparinized to maintain an ACT  250 seconds. Long
occlusions are typically crossed with .035-inch angled glide
wires in the superficial femoral artery (SFA) and popliteal
trying to avoid subintimal dissection if possible. Tibial
lesions are then preferentially crossed with a .014-inch or
.018-inch wire, over which a long, noncompliant low-
profile angioplasty balloon sized to match the healthy por-
tion of the artery is advanced, and prolonged inflation to
profile over 2 to 3 minutes is performed. Stents were
selectively used in cases of post-PTA residual stenosis or
flow-limiting dissection. All patients are continued on aspi-
rin indefinitely and given clopidogrel for a minimum of 30
days.
Patient demographics, comorbidities, procedural data,
and follow-up information were recorded in a database.
Detailed information was obtained by reviewing vascular
laboratory data, patient records, and angiographic proce-
dural imaging and included potential risk factors such as
number of lesions, location, TASC classification,7,8 time
from bypass, type of conduit, and bypass target (popliteal,
tibial, or pedal). Patient symptoms and severity were also
included.
Technical success was defined as a residual stenosis less
than 30%. Perioperative events including bleeding, myocar-
dial infarction, stroke, or death were recorded. Survival
information was obtained from office visits, telephone con-
tacts, or the Social Security Death Index for patients lost to
follow-up. Follow-up visit and duplex ultrasounds were
scheduled at 1, 3, and 6 months followed by 3- to 6-month
intervals thereafter as necessary. Significant restenosis by
duplex, defined as a velocity ratio greater than 3.5 (VR 
peak systolic velocity at the lesion/peak systolic velocity
proximal to lesion), which correlates with greater than 75%
stenosis was followed by redo intervention. All other lesions
were observed. PTA failure was defined as redo-PTA, sur-
gical revision, or amputation. The choice of intervention
was based on surgeon preferences and patient characteris-
tics. Statistical analysis was performed with descriptive,
logistic regression, log-rank test, and Kaplan-Meier life-
table analyses. This study was approved by the Beth Israel
Deaconess Medical Center institutional review board.
RESULTS
We identified 24 lower extremities in 23 patients who
underwent infrainguinal PTA of their native circulation for
failed bypass grafts with critical limb ischemia. Patient
demographics and comorbidities are listed in Table I. Me-
dian age was 68 years (range 51-85). Sixty-two percent
were (61%) male and 81% had diabetes mellitus (DM).
Average patency of the index graft before failure was 21.6
months (range 0.2-92). Only two patients presented in the
early postoperative period (within 30 days) with a failed
graft. All patients had critical limb ischemia with rest pain,
ulcers, or gangrene. No claudicants were included in this
cohort.Primary therapy was PTA in all 24 limbs with three
requiring a subintimal approach. Twelve (50%) interven-
tions required adjunctive stenting due to residual stenosis
or dissection. Eighty-three percent (83%) of limbs treated
had multiple lesions (femoral, popliteal, tibial, or pedal)
(Table II) and 87% included TASC C and D lesions.
Technical success was 100%, with restoration of in-line flow
to the foot. There were four (16%) periprocedural myocar-
dial infarctions and one early stent thrombosis (within 4
days), which required reintervention ultimately leading to
an early below the knee amputation due to lack of adequate
outflow. There were no access site complications or
periprocedural deaths. Mean follow-up was 25.6 months
(median 25.3 [range 1.3-38 months]). At follow-up, there
were 17 PTA failures, which resulted in: amputation (4),
redo-bypass (3), and redo-PTA (11). The redo bypasses
were all performed to a more distal target vessel than the
original bypass and included a femoral to posterior tibial, a
below the knee popliteal to dorsalis pedis and a femoral to
below the knee popliteal bypass.
Kaplan Meier survival analysis demonstrated that free-
dom from PTA failure (PTA primary patency) was 28%
(/ 0.09 SE), whereas secondary patency was 72.4%
(/ 0.09 SE) at 12 months (Fig 1), while freedom from
surgical revision was 89.5% (/ 0.07 SE) (Fig 2) and
Table I. Demographics
No. or
Median
% or
Range
Age (y) 67 51-85
Male 16 62
Comorbidities
Coronary artery disease 14 58
Diabetes mellitus 21 87
Hypertension 19 79
Hypercholesterolemia 9 37
Chronic renal insufficiency (Cr  1.2) 7 29
Smoking 6 25
Cancer or hypercoagulable state 2 8
Hemodialysis 0 0
Previous bypass target
Popliteal 3 12.5
Tibial Pedal 14 58.3
Pedal 7 29.2
PTA most distal target
Popliteal 2 8.3
Tibial Pedal 20 83.3
Pedal 2 8.3
Multiple targets treated 20 83.3
PTA, Percutaneous balloon angioplasty.
Table II. Distribution of lesions treated
Patients (%) Femoropopliteal Tibial Pedal
Multiple lesions 20 (83.3) 22 23 2
Single lesion 4 (16.7) 1 3 0
Total 24 (100) 23 26 2limb-salvage was 81.5% (/ 0.08 SE) at both 12 and 24
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and 77 % (/ 0.09 SE) at 12 and 24months, respectively
(Fig 4). The presence of a TASC D lesion in a treated limb,
was found to be the only significant risk factor for PTA
failure (hazard ratio [HR], 5.98; 95% CI, 1.3-27.0, P
.02) by univariate analysis (Table III). No other variables
were found to be significant by multivariate analysis.
Five patients underwent postprocedure minor amputa-
tions, of these, only two ultimately healed. Although the
target of the original failed bypass was not identified as a
significant risk factor for PTA failure, we found that a
previous popliteal bypass was associated with a significantly
increased risk to undergo a redo bypass procedure com-
pared with a previous tibial or distal bypass (P  .0001).
This is likely a function of the anatomical requirements or
lack thereof, to perform such bypasses (ie, target, conduit).
DISCUSSION
Despite continuous improvements in medical and sur-
gical therapies, lower extremity bypass failure remains a
challenging problem for vascular surgeons. Redo bypass for
stenosis or impending graft failure carries a significant risk
for most of these patients with a 25% complication rate,
including 12% of cardiac complications and 1% periproce-
Fig 1. Primary and secondary PTA patency after failed lower
extremity bypass.
PTA patency 12 mo 24 mo 36 mo
Primary patency
No at risk 6 5 2
No of events 16 0 1
KM estimate 0.283 0.283 0.189
Standard error 0.097 0.097 0.10
Secondary patency
No. at risk 12 8 3
No. of events 6 0 1
KM estimate 0.723 0.723 0.543
Standard error 0.096 0.096 0.172
PTA, Percutaneous balloon angioplasty; KM, Kaplan-Meier; SE, standard
error.dural mortality, with 66% limb salvage rates at 5 years incases with critical limb ischemia.9 On the other hand, while
PTA of infrainguinal vein grafts is a viable, safe, and effec-
tive alternative to preserve graft function with limb salvage
rates of 91% at 2 years, it should likely be limited to those
Fig 2. Freedom from surgical revision.
Freedom from surgical revision 12 mo 24 mo 36 mo
No. at risk 12 8 3
No. of events 2 0 1
KM estimate 0.894 0.894 0.671
Standard error 0.070 0.070 0.200
PTA, Percutaneous balloon angioplasty; KM, Kaplan-Meier; SE, standard
error.
Fig 3. Limb salvage after PTA for failed lower extremity bypass.
Freedom from amputation 12 mo 24 mo 36 mo
No. at risk 13 9 5
No. of events 4 0 0
KM estimate 0.814 0.814 0.814
Standard error 0.084 0.084 0.084
PTA, Percutaneous balloon angioplasty; KM, Kaplan-Meier; SE, standard
error.patent bypass grafts with favorable anatomical features.10,11
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grafts, who are not surgical candidates due to either severe
comorbidity or anatomical reasons with very limited oppor-
tunity to avoid amputation.
Our study shows that lower extremity PTA in the
setting of limb threatening ischemia due to a failed bypass
graft is a safe and effective strategy in limb salvage. This
makes it a particularly important modality, in those patients
who have no other conduit or revascularization options. A
contemporary series established how in patients with criti-
cal limb ischemia, infrapopliteal PTA demonstrated a limb
salvage rate of 84% up to 3 years,5 with the provision that
these patients will require very close follow-up and low
threshold for reintervention. Taylor et al reported their
comparative data between PTA vs amputation for critical
limb ischemia with limb salvage rate of 63% and 3.8%
mortality in the PTA group at 12 months.12
Despite our relative high periprocedural myocardial
Fig 4. Overall survival after PTA for failed lower extremity by-
pass.
Overall Survival 12 mo 24 mo 36 mo
No. at risk 18 13 8
No. of events 4 1 1
KM estimate 0.831 0.772 0.701
Standard error 0.077 0.091 0.107
PTA, Percutaneous balloon angioplasty; KM, Kaplan-Meier; SE, standard
error.
Table III. Worst lesion treated in a limb: TASC
classification and risk of PTA failure
TASC classification
(worst lesion) No. % HR 95% CI
TASC A 0 0 — —
TASC B 3 11.5 0.22 0.03-1.7
TASC C 3 11.5 0.24 0.03-1.8
TASC D 18 69.2 5.98 1.3-27.0
TASC, TransAtlantic InterSociety Consensus classification; PTA, percuta-
neous balloon angioplasty; HR, hazard ratio; CI, confidence interval.infarction rate of 16%, which likely represents the severity ofcardiovascular disease in this selected patient cohort, our
data compares favorably to the aforementioned, with no
perioperative mortality and limb salvage rate of 81% up to 3
years, despite the frequency of highly unfavorable lesions,
namely TASC C and D lesions, which we encountered in
more than 87% of limbs treated. This certainly correlated
with our high rate of stenting (50%) and reintervention due
to early PTA failure. Univariate analysis showed a sixfold
increased risk of procedural failure with TASC D lesions.
These findings are similar to those of Giles et al who found
increased risk of stenosis, reintervention, and amputation in
this group of patients.5
We also found that the presence of a previous failed
bypass, adds to the complexity of the procedure, since the
number of lesions that need to be treated increases and the
distal target is almost always located further downstream
from the previous bypass into a smaller vessel. We here
found that angioplasty distal targets (tibial or pedal) were
found and treated in 92% of cases, compared with 87% for
previous failed bypasses. Careful wire and catheter handling
techniques at this level are extremely important in order to
achieve procedural success. Long- term outcomes will
greatly depend on a very strict follow-up schedule with
arterial duplex surveillance and likely reintervention to
maintain patency. Our surveillance protocol calls for duplex
ultrasounds at 1, 3, and 6 months followed by 3- to
6-month intervals thereafter for these patients.
The small number of patients limited our ability to
identify other predictors of PTA failure. Nonetheless, our
data clearly states how PTA in patients with limb threaten-
ing ischemia whom already have failed bypass grafts and
have limited options for revascularization, have improved
limb salvage rates as long as they are subjected to a close
follow-up regimen and reintervention as needed.
CONCLUSION
We conclude that endovascular treatment of patients
with limb threat and failed bypass grafts leads to a substan-
tially improved rate of limb salvage despite the TASC lesion
classification. This is especially true in patients with no
realistic surgical redo option and should always be consid-
ered before proceeding to amputation.
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